Search results for "indication"

showing 10 items of 114 documents

The Place of Indications of Geographical Origin in the Intellectual Property System

2014

As indicated in the introductory chapter of this book, different designations are used for denoting goods and services in the trade which are not congeneric from the legal point of view. Among those designations, there are also those which contain a reference to a particular geographical place, i.e. geographical designations. This situation is successfully revealed in materials of one international conference by indicating that many designations which are used in commerce may contain a geographical reference (yet their legal nature is different) by distinguishing three different groups of such designations:

Geographical indicationGoods and servicesCommerceGeographyPoint (typography)International treatyEconomic geographyIntellectual propertyUnfair competition
researchProduct

Indirect Protection System

2014

As it was characterised in Chap. 5 of this book, protection of IGOs in the EU law consists of two protection systems: the direct protection system and the indirect protection system. If the first protection system is generally ensured through the applicable Regulations that are applicable without their further transposition into the national law of EU Member States, the other one is generally ensured through directives to be further transposed into the national law of EU Member States.

Geographical indicationMember statesTransposition (telecommunications)BusinessProtection systemLaw and economics
researchProduct

Quality Schemes Regulation

2014

As it was discussed in the previous chapter, the EU direct protection system covers IGOs in relation to agricultural products and foodstuffs and is divided in four parts each of them being regulated in a separate legal act in the form of a regulation. Due to that regulatory approach, each of these separate regulations will be discussed separately in this and the next three chapters. This chapter examines the Quality Schemes Regulation covering, inter alia, IGOs in relation to agricultural products and foodstuffs except spirits (examined in Chap. 7), wine sector products (Chap. 8), and aromatised wines (Chap. 9) (hereinafter all these types of goods (products) referred to as agricultural pro…

Geographical indicationRelation (database)Agriculturebusiness.industryLegal definitionmedia_common.quotation_subjectReservationQuality (business)Protection systembusinessLegal personIndustrial organizationmedia_common
researchProduct

European Politics of Food Origin. A Semiotic Analysis of Geographical Indications

2021

This chapter investigates the relationship between food products and origin places within the European Union food policies. In the 1990s, the EU established a Geographical Indication (GI) system, constituted of a set of food quality brands and a legal framework for food, wine and spirits. This system, defined as a sui generis model by insiders, entails a strong EU government participation in the typical food symbolic and material modelling. The sui generis model establishes a government monopoly on the place-based labels registration and institutes an atypical kind of intellectual property based on geographic marks. By proposing a semiotic approach toward the analysis of European Geographic…

Governmentbusiness.industryBalsamic Vinegar of ModenaEnvironmental ethicsIntellectual propertyFood heritagePoliticsPolitical sciencePDOFood processingmedia_common.cataloged_instanceGeographical indicationProduct (category theory)European unionMonopolybusinessDisciplineFood originSettore M-FIL/05 - Filosofia E Teoria Dei Linguaggimedia_common
researchProduct

Early cardiac unloading with ImpellaCP™ in acute myocardial infarction with ventricular septal defect

2020

Abstract Despite a relative contraindication, mechanical support with Impella™ left ventricular assist device has already been described for ischaemic ventricular septal defect treatment, either as a bridge to surgery, as intraoperative mechanical haemodynamic support, or to ensure intraprocedural haemodynamic stability during device closure. We describe two cases of ventricular septal defect complicating acute myocardial infarction, where the percutaneous ImpellaCP was implanted early (differently than previously described) with the aim of preventing haemodynamic instability, while deferring surgical repair. We present a report of haemodynamic, echocardiographic, biochemical, and clinical …

Heart Septal Defects Ventricularmedicine.medical_specialtyPercutaneousAcute myocardial infarction mechanical complicationmedicine.medical_treatmentMyocardial InfarctionCase ReportLeft ventricular assist device610 Medicine & health030204 cardiovascular system & hematologyVentricular septal defectImpella11171 Cardiocentro Ticino2705 Cardiology and Cardiovascular Medicine03 medical and health sciences0302 clinical medicineInternal medicineDiseases of the circulatory (Cardiovascular) systemMedicineHumans030212 general & internal medicineMyocardial infarctioncardiovascular diseasesContraindicationImpellaSurgical repairbusiness.industryHemodynamicsAcute heart failureHeartPerioperativemedicine.diseaseRC666-701Heart failureVentricular assist deviceCardiologyHeart-Assist DevicesCardiology and Cardiovascular Medicinebusiness
researchProduct

Indicaciones de los inhibidores de PCSK9 en la práctica clínica. Recomendaciones de la Sociedad Española de Arteriosclerosis (SEA), 2019

2019

Resumen Un grupo de expertos convocado por la Sociedad Espanola de Arteriosclerosis (SEA) se ha encargado de actualizar el documento de la SEA sobre las indicaciones de los inhibidores de PCSK9 (iPCSK9) en la practica clinica publicadas en 2016. Esta actualizacion es necesaria porque en el periodo transcurrido hasta la actualidad se han publicado los resultados de los ensayos clinicos realizados a gran escala con iPCSK9 que demuestran que, ademas de su alta potencia para disminuir el colesterol aterogenico, disminuyen el riesgo de presentar episodios de enfermedad cardiovascular aterosclerotica en los pacientes con enfermedad tanto estable como reciente, y con un alto grado de seguridad. La…

Inhibidores de la proproteína convertasa subtilisina kexina 9ArteriosclerosisEnfermedad cardiovascularFamilial hypercholesterolemiaClinical indicationsLow density lipoprotein030204 cardiovascular system & hematologyArteriosclerosi03 medical and health sciencesLipoproteínas de baja densidad0302 clinical medicineIndicaciones clínicasTratamientoPharmacology (medical)030212 general & internal medicineConsensus documentHipercolesterolemia familiarNumber needed to treatCardiovascular diseaseDocumento de consensoTreatmentArterioesclerosiCholesterolProprotein convertase subtilisin kexin 9 inhibitorsCardiology and Cardiovascular MedicineColesterolNúmero necesario a tratar
researchProduct

The colovescical fistula in diverticular disease: Laparoscopic approach in two different cases

2020

Highlights • The colovescical fistula is one of the complications of diverticular disease. • It can cause typical symptoms like pneumaturia and fecaluria affecting the quality of life and sometimes leading to death, usually secondary to sepsis. • We studied two patients with clinical, radiological and endoscopic diagnosis of colovescical fistula as a consequence of diverticular disease. • We performed a totally laparoscopic treatment with colonic resection and closure of the fistula with intracorporeal sutures. • The presence of a colovescical fistula significantly increases the difficult of the laparoscopic colonic resection.

Laparoscopic surgerymedicine.medical_specialtySurgical skillsmedicine.medical_treatmentFistulaCase ReportLaparoscopic colorectal resection03 medical and health sciences0302 clinical medicineFecaluriaComplicated diverticulitismedicineDysuriaLaparoscopic suturesContraindicationPneumaturiamedicine.diagnostic_testbusiness.industryCystoscopymedicine.diseasedigestive system diseasesSurgery030220 oncology & carcinogenesisDiverticular diseaseLaparoscopy030211 gastroenterology & hepatologySurgerymedicine.symptomColovescical fistulabusinessInternational Journal of Surgery Case Reports
researchProduct

The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation

2018

OBJECTIVE: The European Guidelines Meeting on Laparoscopic Liver Surgery was held in Southampton on February 10 and 11, 2017 with the aim of presenting and validating clinical practice guidelines for laparoscopic liver surgery.BACKGROUND: The exponential growth of laparoscopic liver surgery in recent years mandates the development of clinical practice guidelines to direct the speciality's continued safe progression and dissemination.METHODS: A unique approach to the development of clinical guidelines was adopted. Three well-validated methods were integrated: the Scottish Intercollegiate Guidelines Network methodology for the assessment of evidence and development of guideline statements; th…

Liver surgerymedicine.medical_specialtyDelphi TechniqueColorectal cancerindicationMEDLINE030230 surgeryCENTRAL VENOUS-PRESSUREINITIAL-EXPERIENCECOLORECTAL-CANCER03 medical and health sciences0302 clinical medicineSouthamptonOPEN LEFT HEMIHEPATECTOMYHEPATOCELLULAR-CARCINOMAmedicineHepatectomyHumansguidelinesproceduresimplementationPOSTEROSUPERIOR SEGMENTSbusiness.industryLiver DiseasesENERGY DEVICElaparoscopic liver surgerytechniquemedicine.disease2-STAGE HEPATECTOMYEnergy deviceclinical practiceSurgeryEuropeClinical PracticeGLISSONIAN APPROACHconsensus030220 oncology & carcinogenesisHepatocellular carcinomaLaparoscopySurgeryLEARNING-CURVEbusinesspatient selectionAnnals of surgery
researchProduct

Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants

2020

AbstractAs a result of the successful completion of their respective phase III studies compared with vitamin K antagonists (VKAs), four direct oral anticoagulants (DOACs) have been approved for the treatment and secondary prevention of venous thromboembolism (VTE). These DOACs—apixaban, dabigatran, edoxaban, and rivaroxaban—have subsequently seen a steady uptake among clinicians since their approval. Despite the suitability of DOACs for a broad range of patients, they are not appropriate in certain situations, whereas in others they require additional considerations such as dose reductions. Subanalyses of phase III trials and studies on specific VTE patient populations have been conducted t…

Male0301 basic medicineComorbidity030204 cardiovascular system & hematologychemistry.chemical_compound0302 clinical medicinePregnancyEdoxabanNeoplasmsSecondary PreventionChildspecial populationsAge FactorsVenous ThromboembolismHematologyMiddle AgedTreatment OutcomePractice Guidelines as TopicFemaleKidney Diseasesmedicine.drugAdultmedicine.medical_specialtyMEDLINEHemorrhagecomorbiditiesdirect oral anticoagulantsDabigatran03 medical and health sciencesmedicineHumansLactationDosingIntensive care medicineAgedDose-Response Relationship Drugbusiness.industryPatient SelectionPregnancy Complications HematologicContraindications DrugAnticoagulantsmedicine.diseaseComorbidityReview articleClinical trial030104 developmental biologyClinical Trials Phase III as TopicchemistrybusinessVenous thromboembolismFactor Xa InhibitorsThrombosis and Haemostasis
researchProduct

Modeling Right Ventricle Failure After Continuous Flow Left Ventricular Assist Device: A Biventricular Finite-Element and Lumped-Parameter Analysis

2017

The risk of right ventricle (RV) failure remains a major contraindication for continuous-flow left ventricular assist device (CF-LVAD) implantation in patients with heart failure. It is therefore critical to identify the patients who will benefit from early intervention to avoid adverse outcomes. We sought to advance the computational modeling description of the mechanisms underlying RV failure in LVAD-supported patients. RV failure was studied by computational modeling of hemodynamic and cardiac mechanics using lumped-parameter and biventricular finite element (FE) analysis. Findings were validated by comparison of bi-dimensional speckle-tracking echocardiographic strain assessment of the …

MaleCardiac CatheterizationCardiac outputVentricular Dysfunction Rightmedicine.medical_treatmentHemodynamicsSpeckle tracking echocardiography02 engineering and technology030204 cardiovascular system & hematologySeverity of Illness IndexRight ventricular failure Left ventricular assist device Speckle-tracking echocardiography Lumped-parameter Finite-element analysis.Ventricular Function LeftVentricular Dysfunction Left0302 clinical medicineRisk FactorsMedicineModels CardiovascularMiddle AgedTreatment Outcomemedicine.anatomical_structureEchocardiographyCardiologyFemaleCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyFinite Element Analysis0206 medical engineeringBiomedical EngineeringProsthesis DesignProsthesis Implantation03 medical and health sciencesInternal medicineSettore ING-IND/12 - Misure Meccaniche E TermicheHumansComputer SimulationInterventricular septumContraindicationRetrospective StudiesHeart Failurebusiness.industryHemodynamicsmedicine.disease020601 biomedical engineeringVentricleVentricular assist deviceHeart failureVentricular Function RightHeart-Assist DevicesbusinessCardiovascular Engineering and Technology
researchProduct